Global Biodefense Market Size, Status and Forecast 2022

Q: How big is the Biodefense Market?

Ans. In 2021, the global Biodefense market size will be US$ 1144 million and it is expected to reach US$ 1746 million by the end of 2027, with a CAGR of 7.3% during 2021-2027.

Q: Who are the major players available in the Biodefense Industry?

Ans. The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market.

Q: Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

Q: Which segment holds largest market share in the Biodefense?

Ans. Anthrax and Smallpox are main types, with a share about 70%.

Q: Which is the major application in the Biodefense market?

Ans. US Civilian Market is the main application, which holds a share about 55%.

Code: QYRE-Auto-37U9019

Report

January 2022

115 Pages

QYResearch

Region: Global

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Government

Emergent Biosolutions

Ichor Medical Systems

Aeolus Pharmaceuticals

Alnylam Pharmaceuticals

Biodefense Market

In 2021, the global Biodefense market size will be USD 1144 Million and it is expected to reach USD 1746 Million by the end of 2027, with a CAGR of 7.3% during 2021-2027.

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

Biodefense Market Share

The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.

This report focuses on the global Biodefense status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Biodefense development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Biodefense market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biodefense market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Biodefense Market Segmentation

By Type

Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others

By Application

US Military Market
US Civilian Market
Non - US Market

By Region

North America
Europe
Japan
China
Southeast Asia
India

By Company

Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals

Scope of Biodefense Market Report

Report Metric	Details
Report Name	Biodefense Market
Market size value in 2021	USD 1144 Million
Revenue forecast in 2027	USD 1746 Million
Growth Rate	7.3%
Base year considered	2021
Forecast Period	2021-2027
By Type	Anthrax, Smallpox, Botulism, Radiation/Nuclear
By Application	US Military Market, US Civilian Market, Non - US Market
Report Coverage	Revenue & volume forecast, company share, competitive landscape, growth factors, and trends
Segments Covered	By Type, Application, and Region
Geographic Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. How big is the Biodefense Market?

Ans. In 2021, the global Biodefense market size will be US$ 1144 million and it is expected to reach US$ 1746 million by the end of 2027, with a CAGR of 7.3% during 2021-2027.

2. Who are the major players available in the Biodefense Industry?

Ans. The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market.

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

4. Which segment holds largest market share in the Biodefense?

Ans. Anthrax and Smallpox are main types, with a share about 70%.

5. Which is the major application in the Biodefense market?

Ans. US Civilian Market is the main application, which holds a share about 55%.

Recommended Reports

Vaccine Markets

Biotherapeutics

Vaccine Delivery

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biodefense Market Size Growth Rate by Type (2021-2027)

1.2.2 Anthrax

1.2.3 Smallpox

1.2.4 Botulism

1.2.5 Radiation/Nuclear

1.2.6 Others

1.3 Market by Application

1.3.1 Global Biodefense Market Share by Application (2021-2027)

1.3.2 US Military Market

1.3.3 US Civilian Market

1.3.4 Non - US Market

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Biodefense Market Size

2.2 Biodefense Market Size by Regions

2.2.1 Biodefense Growth Rate by Regions (2021-2027)

2.2.2 Biodefense Market Share by Regions (2021-2027)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Use Cases

3 Key Players

3.1 Biodefense Revenue by Players (2020-2021)

3.2 Biodefense Key Players Headquaters and Area Served

3.3 Key Players Biodefense Product/Solution/Service

3.4 Date of Enter into Biodefense Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application

4.1 Global Biodefense Market Size by Type (2021-2027)

4.2 Global Biodefense Market Size by Application (2021-2027)

5 North America

5.1 North America Biodefense Market Forecast (2021-2027)

5.2 Biodefense Key Players in North America

5.3 North America Biodefense Market Size by Type

5.4 North America Biodefense Market Size by Application

6.4.4 Canada

6 Europe

6.1 Europe Biodefense Market Forecast (2021-2027)

6.2 Biodefense Key Players in Europe

6.3 Europe Biodefense Market Size by Type

6.4 Europe Biodefense Market Size by Application

7 Japan

7.1 Japan Biodefense Market Forecast (2021-2027)

7.2 Biodefense Key Players in Europe

7.3 Japan Biodefense Market Size by Type

7.4 Japan Biodefense Market Size by Application

8 Rest of World

8.1 China

8.1.1 China Biodefense Market Analysis

8.1.2 Key Players in China

8.2 Southeast Asia

8.2.1 Southeast Asia Biodefense Market Analysis

8.2.2 Key Players in Southeast Asia

8.3 India

8.3.1 India Biodefense Market Analysis

8.3.2 Key Players in India

9 International Player Profiles

9.1 Emergent Biosolutions

9.1.1 Emergent Biosolutions Company Details

9.1.2 Emergent Biosolutions Description and Business Overview

9.1.3 Emergent Biosolutions Biodefense Introduction

9.1.4 Emergent Biosolutions Revenue in Biodefense Business (2020-2021)

9.1.5 Emergent Biosolutions Recent Development

9.2 Hytest

9.2.1 Hytest Company Details

9.2.2 Hytest Description and Business Overview

9.2.3 Hytest Biodefense Introduction

9.2.4 Hytest Revenue in Biodefense Business (2020-2021)

9.2.5 Hytest Recent Development

9.3 GSK

9.3.1 GSK Company Details

9.3.2 GSK Description and Business Overview

9.3.3 GSK Biodefense Introduction

9.3.4 GSK Revenue in Biodefense Business (2020-2021)

9.3.5 GSK Recent Development

9.4 Sanofi

9.4.1 Sanofi Company Details

9.4.2 Sanofi Description and Business Overview

9.4.3 Sanofi Biodefense Introduction

9.4.4 Sanofi Revenue in Biodefense Business (2020-2021)

9.4.5 Sanofi Recent Development

9.5 PharmAthene

9.5.1 PharmAthene Company Details

9.5.2 PharmAthene Description and Business Overview

9.5.3 PharmAthene Biodefense Introduction

9.5.4 PharmAthene Revenue in Biodefense Business (2020-2021)

9.5.5 PharmAthene Recent Development

9.6 Bavarian Nordic

9.6.1 Bavarian Nordic Company Details

9.6.2 Bavarian Nordic Description and Business Overview

9.6.3 Bavarian Nordic Biodefense Introduction

9.6.4 Bavarian Nordic Revenue in Biodefense Business (2020-2021)

9.6.5 Bavarian Nordic Recent Development

9.7 SIGA Technologies

9.7.1 SIGA Technologies Company Details

9.7.2 SIGA Technologies Description and Business Overview

9.7.3 SIGA Technologies Biodefense Introduction

9.7.4 SIGA Technologies Revenue in Biodefense Business (2020-2021)

9.7.5 SIGA Technologies Recent Development

9.8 Arbutus Biopharma

9.8.1 Arbutus Biopharma Company Details

9.8.2 Arbutus Biopharma Description and Business Overview

9.8.3 Arbutus Biopharma Biodefense Introduction

9.8.4 Arbutus Biopharma Revenue in Biodefense Business (2020-2021)

9.8.5 Arbutus Biopharma Recent Development

9.9 DynPort Vaccine

9.9.1 DynPort Vaccine Company Details

9.9.2 DynPort Vaccine Description and Business Overview

9.9.3 DynPort Vaccine Biodefense Introduction

9.9.4 DynPort Vaccine Revenue in Biodefense Business (2020-2021)

9.9.5 DynPort Vaccine Recent Development

9.10 Xoma Corporation

9.10.1 Xoma Corporation Company Details

9.10.2 Xoma Corporation Description and Business Overview

9.10.3 Xoma Corporation Biodefense Introduction

9.10.4 Xoma Corporation Revenue in Biodefense Business (2020-2021)

9.10.5 Xoma Corporation Recent Development

9.11 Ichor Medical Systems

9.11.1 Ichor Medical Systems Company Details

9.11.2 Ichor Medical Systems Description and Business Overview

9.11.3 Ichor Medical Systems Biodefense Introduction

9.11.4 Ichor Medical Systems Revenue in Biodefense Business (2020-2021)

9.11.5 Ichor Medical Systems Recent Development

9.12 Aeolus Pharmaceuticals

9.12.1 Aeolus Pharmaceuticals Company Details

9.12.2 Aeolus Pharmaceuticals Description and Business Overview

9.12.3 Aeolus Pharmaceuticals Biodefense Introduction

9.12.4 Aeolus Pharmaceuticals Revenue in Biodefense Business (2020-2021)

9.12.5 Aeolus Pharmaceuticals Recent Development

9.13 Achaogen

9.13.1 Achaogen Company Details

9.13.2 Achaogen Description and Business Overview

9.13.3 Achaogen Biodefense Introduction

9.13.4 Achaogen Revenue in Biodefense Business (2020-2021)

9.13.5 Achaogen Recent Development

9.14 Elusys Therapeutics

9.14.1 Elusys Therapeutics Company Details

9.14.2 Elusys Therapeutics Description and Business Overview

9.14.3 Elusys Therapeutics Biodefense Introduction

9.14.4 Elusys Therapeutics Revenue in Biodefense Business (2020-2021)

9.14.5 Elusys Therapeutics Recent Development

9.15 Dynavax Technologies

9.15.1 Dynavax Technologies Company Details

9.15.2 Dynavax Technologies Description and Business Overview

9.15.3 Dynavax Technologies Biodefense Introduction

9.15.4 Dynavax Technologies Revenue in Biodefense Business (2020-2021)

9.15.5 Dynavax Technologies Recent Development

9.16 Cleveland BioLabs

9.16.1 Company Details

9.16.2 Cleveland BioLabs Description and Business Overview

9.16.3 Cleveland BioLabs Biodefense Introduction

9.16.4 Cleveland BioLabs Revenue in Biodefense Business (2020-2021)

9.16.5 Cleveland BioLabs Recent Development

9.17 Soligenix

9.17.1 Soligenix Company Details

9.17.2 Soligenix Description and Business Overview

9.17.3 Soligenix Biodefense Introduction

9.17.4 Soligenix Revenue in Biodefense Business (2020-2021)

9.17.5 Soligenix Recent Development

9.18 Alnylam Pharmaceuticals

9.18.1 Alnylam Pharmaceuticals Company Details

9.18.2 Alnylam Pharmaceuticals Description and Business Overview

9.18.3 Alnylam Pharmaceuticals Biodefense Introduction

9.18.4 Alnylam Pharmaceuticals Revenue in Biodefense Business (2020-2021)

9.18.5 Alnylam Pharmaceuticals Recent Development

10 Market Dynamics

10.1 Industry Trends

10.2 Market Drives

10.3 Market Challenges

10.4 Market Restraints

11 Key Findings in This Report

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.2 Data Source

12.2 Disclaimer

12.3 Author Details

FEATURED COMPANIES

Government

Emergent Biosolutions

Ichor Medical Systems

Aeolus Pharmaceuticals

Alnylam Pharmaceuticals

List of Tables

Table 1. Global Biodefense Market Size Growth Rate by Type (2021-2027) (US$ Million)

Table 2. Key Players of Anthrax

Table 3. Key Players of Smallpox

Table 4. Key Players of Botulism

Table 5. Key Players of Radiation/Nuclear

Table 6. Key Players of Others

Table 7. Global Biodefense Market Size Growth by Application (2021-2027) (US$ Million)

Table 8. Global Biodefense Market Size by Regions (2021-2027) (US$ Million)

Table 9. Global Biodefense Market Share by Regions (2021-2027)

Table 10. Market Top Trends

Table 11. Market Use Cases

Table 12. Global Biodefense Revenue by Players (2020-2021) (US$ Million)

Table 13. Global Biodefense Market Share by Players (2020-2021)

Table 14. Key Players Headquarters and Area Served

Table 15. Key Players Biodefense Product Solution and Service

Table 16. Date of Enter into Biodefense Market

Table 17. Mergers & Acquisitions, Expansion Plans

Table 18. Global Biodefense Market Size by Type (2021-2027) (US$ Million)

Table 19. Global Biodefense Market Size Share by Type (2021-2027)

Table 20. Global Biodefense Market Size by Application (2021-2027) (US$ Million)

Table 21. Global Biodefense Market Size Share by Application (2021-2027)

Table 22. North America Key Players Biodefense Revenue (2020-2021) (US$ Million)

Table 23. North America Key Players Biodefense Market Share (2020-2021)

Table 24. North America Biodefense Market Size by Type (2021-2027) (US$ Million)

Table 25. North America Biodefense Market Share by Type (2021-2027)

Table 26. North America Biodefense Market Size by Application (2021-2027) (US$ Million)

Table 27. North America Biodefense Market Share by Application (2021-2027)

Table 28. Europe Key Players Biodefense Revenue (2020-2021) (US$ Million)

Table 29. Europe Key Players Biodefense Market Share (2020-2021)

Table 30. Europe Biodefense Market Size by Type (2021-2027) (US$ Million)

Table 31. Europe Biodefense Market Share by Type (2021-2027)

Table 32. Europe Biodefense Market Size by Application (2021-2027) (US$ Million)

Table 33. Europe Biodefense Market Share by Application (2021-2027)

Table 34. Japan Key Players Biodefense Revenue (2020-2021) (US$ Million)

Table 35. Japan Key Players Biodefense Market Share (2020-2021)

Table 36. Japan Biodefense Market Size by Type (2021-2027) (US$ Million)

Table 37. Japan Biodefense Market Share by Type (2021-2027)

Table 38. Japan Biodefense Market Size by Application (2021-2027) (US$ Million)

Table 39. Japan Biodefense Market Share by Application (2021-2027)

Table 40. Key Players in China

Table 41. Key Players in Southeast Asia

Table 42. Key Players in India

Table 43. Emergent Biosolutions Company Details

Table 44. Emergent Biosolutions Description and Business Overview

Table 45. Emergent Biosolutions Biodefense Product

Table 46. Emergent Biosolutions Revenue in Biodefense Business 2020 and 2021

Table 47. Emergent Biosolutions Recent Development

Table 48. Hytest Company Details

Table 49. Hytest Description and Business Overview

Table 50. Hytest Biodefense Product

Table 51. Hytest Revenue in Biodefense Business 2020 and 2021

Table 52. Hytest Recent Development

Table 53. GSK Company Details

Table 54. GSK Description and Business Overview

Table 55. GSK Biodefense Product

Table 56. GSK Revenue in Biodefense Business 2020 and 2021

Table 57. GSK Recent Development

Table 58. Sanofi Company Details

Table 59. Sanofi Description and Business Overview

Table 60. Sanofi Biodefense Product

Table 61. Sanofi Revenue in Biodefense Business 2020 and 2021

Table 62. Sanofi Recent Development

Table 63. PharmAthene Company Details

Table 64. PharmAthene Description and Business Overview

Table 65. PharmAthene Biodefense Product

Table 66. PharmAthene Revenue in Biodefense Business 2020 and 2021

Table 67. PharmAthene Recent Development

Table 68. Bavarian Nordic Company Details

Table 69. Bavarian Nordic Description and Business Overview

Table 70. Bavarian Nordic Biodefense Product

Table 71. Bavarian Nordic Revenue in Biodefense Business 2020 and 2021

Table 72. Bavarian Nordic Recent Development

Table 73. SIGA Technologies Company Details

Table 74. SIGA Technologies Description and Business Overview

Table 75. SIGA Technologies Biodefense Product

Table 76. SIGA Technologies Revenue in Biodefense Business 2020 and 2021

Table 77. SIGA Technologies Recent Development

Table 78. Arbutus Biopharma Company Details

Table 79. Arbutus Biopharma Description and Business Overview

Table 80. Arbutus Biopharma Biodefense Product

Table 81. Arbutus Biopharma Revenue in Biodefense Business 2020 and 2021

Table 82. Arbutus Biopharma Recent Development

Table 83. DynPort Vaccine Company Details

Table 84. DynPort Vaccine Description and Business Overview

Table 85. DynPort Vaccine Biodefense Product

Table 86. DynPort Vaccine Revenue in Biodefense Business 2020 and 2021

Table 87. DynPort Vaccine Recent Development

Table 88. Xoma Corporation Company Details

Table 89. Xoma Corporation Description and Business Overview

Table 90. Xoma Corporation Biodefense Product

Table 91. Xoma Corporation Revenue in Biodefense Business 2020 and 2021

Table 92. Xoma Corporation Recent Development

Table 93. Ichor Medical Systems Company Details

Table 94. Ichor Medical Systems Description and Business Overview

Table 95. Ichor Medical Systems Biodefense Product

Table 96. Ichor Medical Systems Revenue in Biodefense Business 2020 and 2021

Table 97. Ichor Medical Systems Recent Development

Table 98. Aeolus Pharmaceuticals Company Details

Table 99. Aeolus Pharmaceuticals Description and Business Overview

Table 100. Aeolus Pharmaceuticals Biodefense Product

Table 101. Aeolus Pharmaceuticals Revenue in Biodefense Business 2020 and 2021

Table 102. Aeolus Pharmaceuticals Recent Development

Table 103. Achaogen Company Details

Table 104. Achaogen Description and Business Overview

Table 105. Achaogen Biodefense Product

Table 106. Achaogen Revenue in Biodefense Business 2020 and 2021

Table 107. Achaogen Recent Development

Table 108. Elusys Therapeutics Company Details

Table 109. Elusys Therapeutics Description and Business Overview

Table 110. Elusys Therapeutics Biodefense Product

Table 111. Elusys Therapeutics Revenue in Biodefense Business 2020 and 2021

Table 112. Elusys Therapeutics Recent Development

Table 113. Dynavax Technologies Company Details

Table 114. Dynavax Technologies Description and Business Overview

Table 115. Dynavax Technologies Biodefense Product

Table 116. Dynavax Technologies Revenue in Biodefense Business 2020 and 2021

Table 117. Dynavax Technologies Recent Development

Table 118. Cleveland BioLabs Company Details

Table 119. Cleveland BioLabs Description and Business Overview

Table 120. Cleveland BioLabs Biodefense Product

Table 121. Cleveland BioLabs Revenue in Biodefense Business 2020 and 2021

Table 122. Cleveland BioLabs Recent Development

Table 123. Soligenix Company Details

Table 124. Soligenix Description and Business Overview

Table 125. Soligenix Biodefense Product

Table 126. Soligenix Revenue in Biodefense Business 2020 and 2021

Table 127. Soligenix Recent Development

Table 128. Alnylam Pharmaceuticals Company Details

Table 129. Alnylam Pharmaceuticals Description and Business Overview

Table 130. Alnylam Pharmaceuticals Biodefense Product

Table 131. Alnylam Pharmaceuticals Revenue in Biodefense Business 2020 and 2021

Table 132. Alnylam Pharmaceuticals Recent Development

Table 133. Biodefense Market Trends

Table 134. Biodefense Market Drivers

Table 135. Biodefense Market Challenges

Table 136. Biodefense Market Restraints

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biodefense Market Share by Type in 2021 & 2027

Figure 2. Anthrax Features

Figure 3. Smallpox Features

Figure 4. Botulism Features

Figure 5. Radiation/Nuclear Features

Figure 6. Others Features

Figure 7. Global Biodefense Market Share by Application in 2021 & 2027

Figure 8. US Military Market Case Studies

Figure 9. US Civilian Market Case Studies

Figure 10. Non - US Market Case Studies

Figure 11. Biodefense Report Years Considered

Figure 12. Global Biodefense Market Size and Growth Rate (2020-2027) (US$ Million)

Figure 13. Global Biodefense Market Share by Regions (2020-2027)

Figure 14. Global Biodefense Market Share by Players in 2021

Figure 15. Global Biodefense Market Size Market Share by Type (2021-2027)

Figure 16. Global Biodefense Market Size Market Share by Application (2021-2027)

Figure 17. Global Biodefense Revenue Market Share by Application in 2021

Figure 18. North America Biodefense Market Size 2021-2027 (US$ Million)

Figure 19. Europe Biodefense Market Size 2021-2027 (US$ Million)

Figure 20. Japan Biodefense Market Size 2021-2027 (US$ Million)

Figure 21. Biodefense Market Size in China (2021-2027) (US$ Million)

Figure 22. Biodefense Market Size in Southeast Asia (2021-2027) (US$ Million)

Figure 23. Biodefense Market Size in India (2021-2027) (US$ Million)

Figure 24. Bottom-up and Top-down Approaches for This Report

Figure 25. Data Triangulation

Figure 26. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bacterial Vaccines Market

DNA Forensic Market

Enzyme Linked Immunosorbent Assay Market

Anti Infective Vaccines Market

Global Pharma Microbiology Testing Kits Market Research Report 2025

Global Pathogen Detection System Market Research Report 2025

Global Microbial Activity Assay System Market Research Report 2025

Global UV Disinfection Nucleic Acid Extraction System Market Research Report 2025

Global Biological Aerosol Detector Market Research Report 2025

Global Emergency Management Service Market Insights, Forecast to 2030

UV Mobile Phone Sterilizer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Ultra-trace Biological Detector - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Biological Defense - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Global Postmortem Toxicology Testing Market Research Report 2024

Global Antibacterial Vaccines Market Research Report 2024

Global and India Forensic Technology Market Report & Forecast 2023-2029

Global and India DNA Forensic Market Report & Forecast 2023-2029

Global and India Biodefense Market Report & Forecast 2023-2029

Global DNA Forensic Solution Market Insights, Forecast to 2029

Global Subscription and Billing Management Software Market Insights and Forecast to 2028

Wireless Testing Market By Offering (Equipment and Services), Technology (Wi-Fi, Bluetooth, 2G/3G, 4G/LTE, and 5G), and Application (Consumer Electronics, IT & Telecommunication, Automotive, Energy & Power, Healthcare, and Other): Global Opportunity Analysis and Industry Forecast, 2021–2028

Global Deep Packet Inspection (DPI) Market Insights and Forecast to 2028

Global Tokenization Market Insights and Forecast to 2028

Global Multi-layer Security Market Insights, Forecast to 2028

Global Biodefense Market Size, Status and Forecast 2022

Published Date: January 2022

Report Code: QYRE-Auto-37U9019

Global Biodefense Market Size, Status and Forecast 2022

FEATURED COMPANIES

Biodefense Market

Biodefense Market Share

Biodefense Market Segmentation

By Type

By Application

By Region

By Company

Scope of Biodefense Market Report

Frequently Asked Questions About This Report

1. How big is the Biodefense Market?

2. Who are the major players available in the Biodefense Industry?

3. Does the report provides covid-19 impact analysis?

4. Which segment holds largest market share in the Biodefense?

5. Which is the major application in the Biodefense market?

Recommended Reports

Vaccine Markets

Biotherapeutics

Vaccine Delivery

FEATURED COMPANIES

RELATED REPORTS